Comparison of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing an invasive strategy: A meta-analysis of randomized clinical trials
Michael S. Lee(University of California, Los Angeles), Ehtisham Mahmud(Cardiovascular Institute of the South), Tae‐Hyun Yang(Inje University Busan Paik Hospital), Jonathan M. Tobis(University of California, Irvine), Gregg C. Fonarow(UCLA Medical Center), Jashdeep Dhoot(University of California, Los Angeles), Hsini Liao(Boston Scientific (United States))
Cited by 48
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
|Circulation|2006|2.1k
The Global Health and Economic Burden of Hospitalizations for Heart Failure
|Journal of the American College of Cardiology|2014|2k
Medical Therapy for Heart Failure With Reduced Ejection Fraction
|Journal of the American College of Cardiology|2018|1.3k